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ABSTRACT
Background: We assessed the results and impact of
blockage of utero-ovarian anastomoses (UOA) on clinical
outcome in women treated by laparoscopic uterine artery
occlusion for uterine fibroids.
Methods: Between 2004 and 2005, we prospectively an-
alyzed the clinical data for 23 laparoscopic uterine artery
occlusion cases combined with blockage of utero-ovarian
anastomoses (Group A) and 67 laparoscopic uterine artery
occlusion cases alone (Group B).
Results: Of these 23 patients with UOA (mean age,
36.72.8 years), 10 patients (43.4%) had anastomoses
bilaterally and 13 patients (56.6%) had unilateral anasto-
moses. Mean fibroid size reduction after LUAO and anas-
tomoses blockage was 32.5% from baseline (P0.001). In
patients with LUAO, the mean DF size after surgery was
estimated at 38.719.2 mm, which translated to a mean
fibroid size reduction of 30.6% from baseline (P0.001).
No case of clinical failure or recurrence was found in
Group A patients with UOA (mean follow-up, 15.6
months), who were treated with combined surgery. At a
mean clinical follow-up of 18.2 months (Group B), 6
patients (8.9%) elected to undergo further surgical inter-
vention for clinical failure and recurrence, including 4
myomectomies and 2 hysterectomies. The statistical dif-
ference between groups was not significant (P0.33).
Conclusion: Laparoscopic blockage of utero-ovarian
anastomoses combined with uterine artery occlusion is a
safe, feasible surgical procedure in women with symp-
tomatic fibroids. Combining the uterine artery occlusion
and blockage of UO anastomoses may be a useful proce-
dure for the decreasing rate of clinical failure and recur-
rence. This premise should be confirmed in a larger pro-
spective multicenter study.
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INTRODUCTION
Uterine artery embolization (UAE) and surgical uterine
artery occlusion are emerging as effective treatment alter-
natives for symptomatic uterine fibroids.1–5 Sound evi-
dence exists for shorter hospital stay, quicker return to
work, and a similar major complication rate compared
with these things with hysterectomy.6 Although the re-
ports have shown great promise for uterine fibroid embo-
lization and laparoscopic uterine artery occlusion (LUAO),
clinical failures for these procedures range from 4% to
39%.7–11 Among that group, there have been women hav-
ing arterial supply to their fibroids from sources other than
the uterine artery. Although anastomoses between the
ovarian and uterine arteries have been studied extensively
in cadavers, postmortem or fresh postoperative speci-
mens, the frequency and importance of such anastomoses
in this patient population have not been well described. In
the September 2002 issue of Radiology, Dr Razavi and
colleagues8 analyzed and classified 3 main angiographic
patterns of utero-ovarian anastomoses (UOA). The pres-
ence of such arterial communications can play an impor-
tant role not only in avoiding nontarget ovarian emboli-
zation, but also in the clinical failure rate of UAE and
LUAO.
We prospectively assessed the frequency of laparoscopi-
cally detectable anastomoses between uterine and ovarian
arteries. The effect of blockage of such arterial communi-
cations on clinical results, safety, and recurrence in
women with symptomatic fibroids treated by LUAO was
studied. The study is part of the prospective Czech mul-
ticenter study of fibroid surgery alternatives treatment
(FSAT).
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SCIENTIFIC PAPERMETHODS
This study carried out in the Department of Obstetrics and
Gynecology, Baby Friendly Hospital Kladno, Czech Re-
public, was a prospective, nonrandomized, cohort, clini-
cal investigation designed to evaluate the frequency,
safety, and effectiveness of blockage of utero-ovarian
anastomoses when used in combination with LUAO for
symptomatic fibroids. This particular study represented an
extension of a previously reported prospective cohort
study that analyzed clinical results, complications, and
fibroid recurrence after laparoscopic uterine artery occlu-
sion for symptomatic fibroids.10 Patients with symptomatic
fibroids, confirmed by ultrasound (US) or magnetic reso-
nance imaging (MRI), were invited to participate in the
study. A total of 90 women were included in this part of
the study over a 12-month, period (2004 to 2005), with 67
women undergoing LUAO and 23 women undergoing
LUAO combined with UOA blockage.
The following inclusion criteria were used: age up to 45
years, dominant symptomatic intramural fibroid of at least
4 cm (in the case of more fibroids, the largest being at least
4cm), and serum concentration of FSH under 30 IU/L.
Elimination criteria: submucous fibroids, size of largest
fibroids 12 cm in greatest diameter (by ultrasound or
MRI), history of amenorrhoea, previous medical therapy
with GnRH agonists, and suspected uterine sarcoma.
Two experienced laparoscopic surgeons (ZH, JL) per-
formed all the operations. Central and local ethics com-
mittee approval was obtained. Presence of utero-ovarian
anastomosis on laparoscopy, peri-operative outcome, size
of dominant fibroid (DF) before and after surgery, clinical
improvement, the rates of clinical failure, and symptom
recurrence were recorded prospectively and analyzed.
Serum concentration of hemoglobin and FSH were taken
preoperatively and 3 months after surgery. The patients
underwent evaluation of symptom status and size of dom-
inant fibroid at 3 to 6 months and yearly after the proce-
dure. In addition, the women were interviewed regarding
changes in bleeding and bulk-related symptoms using a
scale described by Yen et al.12
Anatomical, Angiographic, and Laparoscopic
Description of Utero-ovarian Anastomoses and
Uterus Supply
The ovarian (infundibulopelvic) vessels course medially
through the broad ligament toward the uterine cornu and
consistently give off a branch to the ovary on its lateral
border (Figure 1). The uterine fundus derives its rich
blood supply from the uterine artery and the tubal branch
of the ovarian artery as they anastomose just lateral and
inferior to the junction of the uterine body and the fallo-
pian tube.13 Therefore, selective vessel occlusion of both
these branches (ie, the tubal branch of the ovarian artery
and the uterine artery) will provide a significant reduction
in blood supply to the uterine fibroid.
Three types of utero-ovarian angiographic anastomoses in
women undergoing uterine fibroid embolization have
been described by Razavi et al.8 In type I, flow from the
ovarian artery to the uterus is through anastomoses with
the main uterine artery. In type II, the ovarian artery
supplies the fibroids directly. In type III, the major blood
supply to the ovary is from the uterine artery.
The above-mentioned classification of Razavi et al8 was
simplified and modified for surgical purposes. Type III
was deleted for an impossibility to laparoscopically assess
the direction of blood flow. Utero-ovarian arterial com-
munications were classified into the following 2 surgical
types:
Type I: the ovarian artery connects to the intramural uter-
ine artery before the fibroid supply through the tubo-
ovarian segment. The tubal artery is hypertrophic and
runs toward the uterus, or multiple unnamed small vessels
run between leafs of broad ligament toward the uterus
wall (Figures 2 and 3). Type II: the ovarian artery sup-
plies the fibroid directly.
Figure 1. The dissected tubal branches of ovarian artery on the
right side: laterally, the grasped umbilical ligament and uterine
artery.
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Operative procedures for laparoscopic uterine artery dis-
section, coagulation, and transsection have been previ-
ously described in more detail.10 Briefly, laparoscopy is
performed with the patient in the lithotomy position by
using video-monitoring equipment. Lateral peritoneum
dissection using ultrasonically activated shears (LCS-K5 or
ACE-S, UltraCision, Ethicon EndoSurgery, Johnson &
Johnson Ltd, Cincinnati, OH) is initiated. The peritoneum
is opened, and the paravesical and pararectal space is
developed by blunt dissection. Subsequently, distancing
uterine vessels from the ureter with a safe ultrasonic co-
agulation of the uterine artery and cutting just medial to
their origin from the unobliterated umbilical artery or
hypogastric artery is performed. In some cases, only co-
agulation of the uterine artery is carried out (Figure 3).
Coagulation of utero-ovarian anastomoses vessels using
UltraCision is performed in cases of surgical classifications
type I and type II.
Definition of Clinical Failure and Recurrence
Clinical failure was defined as persistence of symptoms at
3-month follow-up, and recurrence was defined as the
return of symptoms or the regrowth of more than 10% of
fibroids. The main outcome measures were the rates of
hysterectomy and myomectomy. Other factors included in
the data analysis were time interval of symptom recur-
rence and operative and pathologic findings.
Statistical Analysis
Statistical analysis was performed with Fisher’s exact test
when comparing categorical variables with results presented
as meanSD, range, or percentage. The paired Student t test
was used for continuous variables. All tests were 2-sided,
and P0.05 was considered statistically significant.
RESULTS
Eighty-nine (98.9%) patients underwent a successful bilat-
eral LUAO operative procedure with UltraCision with at
least a 12-month follow-up after the operation. One
woman had a unilateral uterine artery dissection. An ab-
sent uterine artery on the right side was later confirmed by
angiography. Anastomoses between uterine and ovarian
arteries were demonstrated by laparoscopy in 23 patients
(25.5%) (Group A). Of these 23 patients with UO anasto-
moses (mean age, 36.72.8 years), 10 patients (43.4%)
had anastomoses bilaterally and 13 patients (56.6%) had
unilateral anastomoses. Type I of UOA surgical classifica-
tion was found in 22 patients (95.6%). In one patient, the
ovarian artery supplied the cornual fibroid directly. No
significant differences existed in age, weight, incidence of
symptoms, and previous myomectomy between Group A
(23 patients with LUAO and blockage of anastomoses)
and Group B (67 patients with LUAO) (Table 1).A ta
mean MRI or US imaging follow-up 16.4 months after
surgery, significant improvement was noted in mean DF
size in both groups (Table 2). Mean fibroid size reduction
after LUAO and anastomoses blockage was 32.5% from
baseline (P0.001). In patients with LUAO, the mean DF
Figure 2. The parauterine collateral between leafs of broad
ligament on the left side.
Figure 3. Anatomical situation after dissection of umbilical lig-
ament and uterine artery on the left side: medially, the coagu-
lated utero-ovarian collateral; caudally, the pressed ureter using
irrigator instrument.
JSLS (2007)11:309–314 311size after surgery was estimated at 38.719.2 mm, which
translated to a mean fibroid size reduction of 30.6% from
baseline (P0.001).
The preoperative blood hemoglobin level and the amount
of clinical improvement after surgery increased signifi-
cantly (P0.01) in both groups (Table 2). All patients had
a normal level of FSH after 3-month follow-up. No case of
amenorrhoea or postmenopausal symptoms occurred.
Only 2 women reported irregular bleeding. For the pa-
tients who underwent LUAO and UOA blockage, the
mean surgery was 35.5 minutes (range, 20 to 50); for those
who underwent only LUAO, it was 36.0 minutes (range,
23 to 55). The mean intraoperative blood loss was
35.214.7 mL in Group A and 28.118.2 mL in Group B.
The hospital stay ranged from 1 day to 4 days, and no
difference was found between the groups (mean, 2.1
days, Group A vs mean, 2.2 days, Group B). No immediate
intraoperative complications occurred. Neuritis of the ob-
turator nerve and fever were observed postoperatively in
2 Group A patients. In 1 Group B patient, with a large
intramural fibroid (8cm), uterine fibroid necrosis devel-
oped 12 weeks after surgery. Successful myomectomy
was carried out by using laparotomy. Neuritis of the ob-
turator nerve was observed in 1 patient, and febris in 3
patients, (Group B). No case of clinical failure or recur-
rence was found in Group A patients with UOA (mean
follow-up,15.6 months), who were treated using com-
bined surgery. At a mean clinical follow-up of 18.2 months
(Group B), 6 patients (8.9%) elected to undergo further
surgical intervention for clinical failure and recurrence,
including 4 myomectomies and 2 hysterectomies. Of
these, hypertrophy of parauterine vessels was observed in
4 of the patients. The difference between groups was not
statistically significant (P0.33) Eight of the 18 women
desiring pregnancy in both groups conceived spontane-
ously. One woman underwent a Caesarean delivery at
week 39, and the second was at week 34 with no com-
plications at the time of the writing of this paper (Group
A). One spontaneous abortion was reported in the first
trimester of pregnancy in a 41-year-old woman, and oth-
ers delivered at full term (Group B). The infants delivered
at full term were normal. Only one growth fetus retarda-
tion in a woman with alcohol and nicotine abuse was
found.
Table 2.
Comparison of Fibroid Sizes and Symptoms Before and After Procedure
Size and Outcome Group A (n  23) Group B (n  67) P Value
Mean DF size before surgery (mm) 55.2  12.4 55.1  13.8 NS
Mean DF size after surgery (mm) 38.2  16.6 38.7  19.2 NS
Hemoglobin before surgery (g/L) 120.1  9.2 123.3  14.3 NS
Hemoglobin after surgery (g/L) 135.9  8.9 138.2  15.6 NS
Clinical improvement
Significantly improved (%) 22 (95.6) 61 (91.0) NS
Slightly improved (%) 1 (4.4) 6 (9.0) NS
Clinical failure and recurrence (%) 0 (0) 6 (8.9) NS
Table 1.
Patient Characteristics
Group A (n  23) Group B (n  67) P Value
Mean age  SD (y) 36.7  2.8 36.4  3.9 NS
Mean weight  SD (kg) 61.9  8.9 59.6  8.2 NS
Menorrhagia (%) 19 (82.6) 56 (83.5) NS
Pain (%) 4 (12.4) 11 (16.5) NS
Previous myomectomy 1 (4.3) 2 (2.9) NS
NS  not significant.
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The ovarian artery can provide significant collateral flow
to the uterus, and the causes of clinical failure of uterine
artery occlusion have not been well studied.7,8,10,14,15
Razavi et al8 prospectively evaluated uterine artery to
ovarian artery anastomoses in 76 consecutive patients
undergoing fibroid embolization and found that 46% of
patients had connections. In that study, 7.9% of women
had bilateral anastomoses of types that could potentially
place them at high risk for ovarian embolization and
therefore premature menopause. In a study by Kim et al,14
the anastomoses between the uterine artery and ovarian
artery on angiography in 40.3% of 288 patients were
demonstrated. The overall repeat intervention rate after
initial UAE was 5.6%, but UAE in patients with anastomo-
ses on angiography was associated with a significantly
higher rate of treatment failure than UAE in patients with-
out anastomoses. Laparoscopic occlusion of parauterine
collaterals also has been successfully performed in a small
group of 11 patients, who were treated by Park et al.15
Authors reported better clinical results in these patients at
12-month follow-up.
To better elucidate the frequency and importance of UOA,
we prospectively studied the patterns of ovarian artery
supply to the fibroids and the uterus in 90 consecutive
patients. Two surgical types of UOA were found in 23
patients (25.5%). Of the 23 patients in this series, type I of
UOA (n22) and type II connections (n1) were ob-
served. All patients underwent laparoscopic coagulation
of UOA in addition to uterine artery occlusion. None of
them reported clinical failure or recurrence. Of the 67
patients in this series without utero-ovarian connection, 6
(8.9%) reported clinical failure and fibroid recurrence after
a period of follow-up (mean, 18.2 months). The difference
between groups was not statistically significant. Possible
causes for treatment failure were likely multifactorial. Two
factors (size of dominant fibroid 6 cm, number of fi-
broids) were previously identified as predictors of recur-
rence of fibroids after LUAO.10 We did not observe any
case of ovarian failure or menopause after utero-ovarian
blockage. This finding supports the results of previous
studies regarding tubal ligation and hormonal chang-
es.16,17 These recent studies show that tubal surgery has
no significant adverse effect on Doppler flow indices and
hormonal markers. Hysterectomy and UAE seem to de-
crease ovarian reserve in peri-menopausal women. Lapa-
roscopic uterine artery occlusion with or without UOA
blockage does not seem to have adverse effects on nor-
mally functioning ovaries.
The enthusiastic information of Park et al15 regarding
patients who had better clinical outcomes after their para-
uterine collaterals were cauterized was not confirmed in
our study. We found that the statistical difference between
groups was not significant. Follow-up of these women
was longer than in the Park et al study.15 With an  error
of 0.05 and a  error of 0.10, we calculated that 60 subjects
and 150 subjects, respectively, would be needed in each
group to determine significance. Laparoscopy may help to
identify collateral flow to the dominant fibroid by way of
tubo-ovarian artery hypertrophy and the small caliber of
the uterine artery. Type III of the angiographic classifica-
tion with blood flow reversal to the ovarian artery is
impossible to detect by laparoscopy. The present study
revealed dilated tortuous parauterine vessels during a sec-
ond look surgery in 4 patients with clinical failure and
recurrence. Of the patients with recurrence, 2 underwent
surgery due to the coexistence of adenomyomas and
fibroids. Although the causes of uterine artery occlusion
treatment failure were multifactorial and still need further
investigation, the results indicate that utero-ovarian collat-
erals can be an important contributor to decreasing clini-
cal failure leading to repeat surgical intervention.
This observational study has several limitations. First, is the
potential inability to detect 3 types of anastomosis. The
second is that we did not attempt to correlate the occurrence
of these types of anastomosis with anatomic factors, such as
dimension of the uterus or fibroids, location of fibroids, and
duration of recent change in symptoms.
CONCLUSION
Laparoscopic blockage of utero-ovarian anastomoses
combined with uterine artery occlusion is a feasible sur-
gical procedure in women with symptomatic fibroids. We
demonstrated anastomoses between the uterine artery
and ovarian artery on laparoscopy in 25.5% of 90 women
studied. Combining the uterine artery occlusion and
blockage of UO anastomoses may be a useful procedure
for decreasing the rate of clinical failure and recurrence.
This premise should be confirmed in a larger prospective
multicenter study.
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